Adagene (ADAG) Receivables - Other (2019 - 2026)
Adagene (ADAG) posted quarterly Receivables - Other of $17.3 billion for Q4 2025, up 108.8% year-over-year from $8.3 billion in Q4 2024, and up 296057920.48% quarter-over-quarter from $5860.0 in Q2 2025.
Analysis
Adagene (ADAG) Receivables - Other (2019 - 2026) Analysis & Trends
Adagene (ADAG) has reported Receivables - Other for 7 consecutive years, with $17.3 billion the latest figure, recorded in Q4 2025.
- In Q4 2025, Receivables - Other rose 108.8% year-over-year to $17.3 billion; the TTM figure through Dec 2025 stood at $17.3 billion (up 108.8% YoY), while the FY2025 annual figure was $17.3 billion, up 108.8% from the prior year.
- Receivables - Other rose to $17.3 billion in Q4 2025 per ADAG's latest filing, from $5860.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $1870.1 billion in Q2 2022 and bottomed at $5860.0 in Q2 2025.
- Historically, Receivables - Other has averaged $313.1 billion across 5 years, with a median of $12.8 billion in 2024.
- Annual changes were most pronounced in 2022 — Receivables - Other jumped 201428797.64% — and 2024, when it sank 100.0%.
- Adagene's Receivables - Other stood at $4.5 million in 2021, then jumped by 13744682.73% to $619.4 billion in 2022, then sank by 64.16% to $222.0 billion in 2023, then tumbled by 96.26% to $8.3 billion in 2024, then jumped by 108.8% to $17.3 billion in 2025.
- Business Quant data shows ADAG's Receivables - Other at $17.3 billion in Q4 2025, $5860.0 in Q2 2025, and $8.3 billion in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Adagene | 211.24 Mn | 211.24 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3,025.00 |
| Dec 31, 2025 | 17,349.00 |
| Jun 30, 2025 | 5,860.00 |
| Dec 31, 2024 | 8,309.00 |
| Jun 30, 2024 | 190,608.00 |
| Dec 31, 2023 | 397,405.00 |
| Jun 30, 2023 | 393,969.00 |
| Dec 31, 2022 | 3.89 Mn |
| Jun 30, 2022 | 1.87 Mn |
| Dec 31, 2021 | -4.37 Mn |
| Jun 30, 2021 | 928,408.00 |
| Dec 31, 2020 | 1.30 Mn |
| Dec 31, 2019 | -704,253.00 |